CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Interventional Radiology in the Era of Radiotheranostics: An Update for Interventional Radiologists!
DOI 10.1055/a-2729-8686
Bibliografische Angaben
Nachweis in CareLit
Autor:innenIslam A.S. Elhelf, Michael Clemenshaw
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe06/2025
Jahrgang / SeitenJg. 64 · S. 352-355
Kernaussage aus der Literatur
Abstract-Vorschau
AbstractIn 2018, the Food and Drug Administration (FDA) approved lutetium-177 (177Lu) DOTATATE (LUTATHERA, Advanced Accelerator Applications [Novartis]) for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Since then, 177Lu DOTATATE has been increasingly used as a treatment option for NETs. Less than 5 years later, in March 2022, 177Lu vipivotide tetraxetan (PL…
Zitieren
Zitierempfehlung
Islam A.S. Elhelf, Michael Clemenshaw (2025) Interventional Radiology in the Era of Radiotheranostics: An Update for Interventional Radiologists!. Nuklearmedizin - NuclearMedicine, 64 (06), 352-355. https://doi.org/10.1055/a-2729-8686
Mit CareLit weiterarbeiten